During the past decade, Engage Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Engage Health" #1 collaborator was "Engage Health Inc." with 3 trials as a collaborator, "Adenoid Cystic Carcinoma Research Foundation" with 1 trials as a collaborator, "GACI Global" with 1 trials as a collaborator, "Hadassah Medical Organization" with 1 trials as a collaborator and "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Engage Health" are "Adenoid Cystic Carcinoma" (1 trials), "Autosomal Recessive Hypophosphatemic Rickets Type 2" (1 trials), "Fabry Disease" (1 trials) and "Generalized Arterial Calcification in Infancy" (1 trials). Many other conditions were trialed in "Engage Health" in a lesser frequency.

Most popular intervention types in "Engage Health" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "This is a non-interventional study" (1 trials). Other intervention names were less common.

The vast majority of trials in "Engage Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Engage Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Engage Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Engage Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".